Senseonics (NASDAQ:SENS) Price Target Raised to $17.00

Senseonics (NASDAQ:SENS) had its price target increased by TD Cowen from $15.00 to $17.00 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other brokerages have also commented on SENS. Mizuho decreased their price objective on Senseonics from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. HC Wainwright restated a “buy” rating and set a $14.00 target price on shares of Senseonics in a research report on Tuesday. Raymond James Financial raised Senseonics from an “underperform” rating to a “market perform” rating in a research note on Tuesday. Stifel Nicolaus reiterated a “hold” rating and issued a $10.00 price target (up from $9.00) on shares of Senseonics in a report on Tuesday. Finally, Wall Street Zen upgraded Senseonics from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Senseonics has an average rating of “Hold” and an average price target of $14.40.

Senseonics Price Performance

Shares of SENS stock opened at $10.04 on Tuesday. Senseonics has a 1 year low of $4.79 and a 1 year high of $13.98. The company has a current ratio of 5.92, a quick ratio of 6.40 and a debt-to-equity ratio of 0.70. The firm’s 50 day moving average is $9.16 and its 200-day moving average is $7.31.

Senseonics (NASDAQ:SENS) last issued its quarterly earnings results on Monday, November 9th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). Senseonics had a negative net margin of 204.01% and a negative return on equity of 186.11%. The company had revenue of $19.56 million during the quarter. As a group, research analysts expect that Senseonics will post -2.30 EPS for the current fiscal year.

Insider Buying and Selling at Senseonics

In other Senseonics news, Director Douglas Roeder purchased 13,953 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The stock was acquired at an average cost of $8.98 per share, with a total value of $125,297.94. Following the completion of the purchase, the director directly owned 171,191 shares in the company, valued at approximately $1,537,295.18. This represents a 8.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Senseonics

Hedge funds and other institutional investors have recently bought and sold shares of the business. State of Wyoming grew its holdings in Senseonics by 27.2% during the 3rd quarter. State of Wyoming now owns 14,940 shares of the company’s stock worth $152,000 after acquiring an additional 3,199 shares during the period. Integrated Wealth Concepts LLC bought a new stake in shares of Senseonics during the 2nd quarter valued at $36,000. Kestra Advisory Services LLC bought a new stake in shares of Senseonics during the 1st quarter valued at $68,000. The Manufacturers Life Insurance Company bought a new stake in shares of Senseonics during the 2nd quarter valued at $65,000. Finally, StoneX Group Inc. bought a new stake in shares of Senseonics during the 3rd quarter valued at $128,000. 12.36% of the stock is owned by institutional investors.

Top Senseonics Stories

Here are a few of the latest stories about SENS:

• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and $14 price target. It also raised its FY2026 estimate and improved its forecasts for FY2028–FY2030, suggesting a more favorable longer-term earnings trajectory. HC Wainwright rating reaffirmed
• Positive Sentiment: Other analyst headlines cite strong price-appreciation outlooks from Mizuho and Barclays, and a TD Cowen price-target increase. Mizuho forecast Barclays forecast TD Cowen target
• Neutral Sentiment: Analyst opinions are not uniformly bullish: Stifel Nicolaus assigned a Hold rating, while Raymond James upgraded SENS to Market Perform. Stifel rating Raymond James rating

About Senseonics

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.